94 related articles for article (PubMed ID: 2163585)
21. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.
Hausfater P; Cacoub P; Sterkers Y; Thibault V; Amoura Z; Nguyen L; Ghillani P; Leblond V; Piette JC
Am J Hematol; 2001 Jul; 67(3):168-71. PubMed ID: 11391713
[TBL] [Abstract][Full Text] [Related]
22. Pleural effusions in hematologic malignancies.
Alexandrakis MG; Passam FH; Kyriakou DS; Bouros D
Chest; 2004 Apr; 125(4):1546-55. PubMed ID: 15078773
[TBL] [Abstract][Full Text] [Related]
23. Identical-twin (syngeneic) marrow transplantation for hematologic cancers.
Fefer A; Cheever MA; Greenberg PD
J Natl Cancer Inst; 1986 Jun; 76(6):1269-73. PubMed ID: 3520068
[TBL] [Abstract][Full Text] [Related]
24. Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.
Taetle R; Rhyner K; Castagnola J; To D; Mendelsohn J
J Clin Invest; 1985 Mar; 75(3):1061-7. PubMed ID: 2984253
[TBL] [Abstract][Full Text] [Related]
25. [Use of a homologous neutrophil suspension for the purpose of correcting peripheral blood circadian biorhythms in children with acute leukemia and lymphosarcoma].
Makhonova LA; Buachidze LN; Maiakova SA; Peterson IS; Berezin AA
Pediatriia; 1979 Dec; (12):17-22. PubMed ID: 583299
[No Abstract] [Full Text] [Related]
26. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
[TBL] [Abstract][Full Text] [Related]
27. Advances in cancer: monoclonal antibody therapy of hematologic malignancies.
Foon KA
N J Med; 1987 Apr; 84(4):269-74. PubMed ID: 3295604
[No Abstract] [Full Text] [Related]
28. CA 125 elevations in patients with malignant lymphomas.
Fehm T; Beck E; Valerius T; Gramatzki M; Jäger W
Tumour Biol; 1998; 19(4):283-9. PubMed ID: 9679739
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies.
Nakase K; Tsuji K; Tamaki S; Tanigawa M; Ikeda T; Miyanishi E; Shiku H
Cancer Detect Prev; 2005; 29(3):256-9. PubMed ID: 15899555
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
31. Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics.
Pamuk GE; Demir M; Harmandar F; Yesil Y; Turgut B; Vural O
Exp Oncol; 2006 Sep; 28(3):241-4. PubMed ID: 17080020
[TBL] [Abstract][Full Text] [Related]
32. Quantity and origin of transplanted autologous blood cells are independent factors associated with speed of postransplant hematological reconstitution.
Rogulj D; Batinić D; Nemet D; Petrovecki M
Croat Med J; 1999 Sep; 40(3):404-8. PubMed ID: 10411969
[TBL] [Abstract][Full Text] [Related]
33. Epithelioid granulomas of the bone marrow in non-Hodgkin's lymphoproliferative malignancies.
Choe JK; Hyun BH; Salazar GH; Ashton JK; Sung CY
Am J Clin Pathol; 1984 Jan; 81(1):19-24. PubMed ID: 6581718
[TBL] [Abstract][Full Text] [Related]
34. Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Barak V; Ginzburg M; Kalickman I; Polliack A
Leuk Lymphoma; 1992 Aug; 7(5-6):431-8. PubMed ID: 1493444
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
36. Lymphoma in Castleman's disease, acute lymphocytic leukemia, adult T-cell leukemia and cutaneous T-cell lymphoma accompanied with high serum soluble Fas ligand levels.
Takubo T; Ohkura H; Kumura T; Ohta K; Yamane T; Hino M; Kamitani T; Tatsumi N
Haematologia (Budap); 2000; 30(1):23-6. PubMed ID: 10841320
[No Abstract] [Full Text] [Related]
37. Serum cholesterol and triglycerides in hematological malignancies.
Marini A; Carulli G; Azzarà A; Grassi B; Ambrogi F
Acta Haematol; 1989; 81(2):75-9. PubMed ID: 2496554
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).
Rodig SJ; Abramson JS; Pinkus GS; Treon SP; Dorfman DM; Dong HY; Shipp MA; Kutok JL
Clin Cancer Res; 2006 Dec; 12(23):7174-9. PubMed ID: 17145843
[TBL] [Abstract][Full Text] [Related]
39. [Bone marrow allograft in adults hemopathies. The Team of the Sterile Unit].
Debusscher L
Rev Med Brux; 1992 May; 13(5):160-6. PubMed ID: 1609190
[TBL] [Abstract][Full Text] [Related]
40. The hematologic malignancies. Leukemia, lymphoma, and myeloma.
Freireich EJ; Keating M; Cabanillas F; Barlogie B
Cancer; 1984 Dec; 54(11 Suppl):2741-50. PubMed ID: 6208991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
